Fabry’s disease is an X-linked recessive Lysosomal Storage disease. The underlying metabolic defect is deficiency of lysosomal enzyme ceramidetrihexosidase. The disease has multisystem involvement. Neurological manifestations include small-fiber polyneuropathy manifested as painful distal extremities and anhidrosis. Fabry’s disease also presents with both small-vessel and cortical multiple cerebral infarcts. Enzyme-replacement therapy has been found effective but expensive. Gene therapy could evolve as the ultimate therapeutic strategy.
Free PDF DownloadTo cite this article
T.K. Banerjee
Fabry disease with special reference to neurological manifestations
Eur Rev Med Pharmacol Sci
Year: 2004
Vol. 8 - N. 6
Pages: 275-281